INDEXED IN: China National Knowledge Infrastructure (CNKI) TURK J NEPHROL IS INDEXED IN WEB OF SCIENCE AND SCOPUS
Turkish Journal of Nephrology
  1. Home
  2. SARC-F is a Weaker Predictor C...
Original Article

SARC-F is a Weaker Predictor Compared to Muscle Strength and a Stronger Predictor Compared to Muscle Mass for Mortality and Hospitalization in Hemodialysis Patients

Yasemin Coşkun Yavuz 1 , Zeynep Biyik 1 , Muslu Kazim Korez 2 , Sedat Abusoglu 3 , Nicat Ahmadlı 4 , Duygu Eryavuz 3 , Elif Batur 5 , Muhammet Cemal Kizilarslanoglu 6 , Serkan Yavuz 7 , Lutfullah Altintepe 1
1.

Department of Nephrology, Selçuk University Faculty of Medicine, Konya, Turkey

2.

Department of Biostatistics, Selçuk University Faculty of Medicine, Konya, Turkey

3.

Department of Biochemistry, Selçuk University Faculty of Medicine, Konya, Turkey

4.

Department of Internal Medicine, Selçuk University Faculty of Medicine, Konya, Turkey

5.

Department of Physical Medicine and Rehabilitation, Selçuk University Faculty of Medicine, Konya, Turkey

6.

Department of Geriatrics, University of Healthy Sciences, Konya City Hospital, Konya, Turkey

7.

Beyhekim Training and Research Hospital, Konya, Turkey

Turkish J Nephrol 2022; 31: 314-320
DOI: 10.5152/turkjnephrol.2022.21124177
Keywords : Hemodialysis, muscle mass, muscle strength, SARC-F, sarcopenia
Read: 911 Downloads: 453 Published: 02 December 2021
Volume 31, Issue 4, October 2022
Previous Article Next Article

Objective: It is known that muscle strength and muscle mass decrease in hemodialysis patients.We aimed to compare the effect of SARC-F (Strength, assistance with walking, rising from a chair, climbing stairs, and falls) questionnaire with that of HGS(hand grip strength) and SMM (BMI) (skeletal muscle mass/body mass index)  on 1year mortality and hospitalization in hemodialysis patients.

Methods: SARC-F test was filled for 67hemodialysis patients,muscle strength was evaluated with HGS,muscle mass was evaluated by performing bioimpedance analysis,and SMM(BMI) was evaluated by calculating using the formula.

Results: The end of 1 year revealed that 12 of 67 patients(17.9%) died.Of the patients,38(56.7%) were hospitalized.The number of hospitalizations was in the range of 0-9.The length of hospitalization varied between2-77days. The patients with low HGS had a 9.86times higher mortality risk (OR=9.862,95% CI=1.190-81.707,p= 0.034) and had a 5.27 times higher risk of hospitalization(OR=5.273,95% CI=1.828-15.207,p=0.002).  The patients who had lower SARC-F had a 3.88 times higher risk of hospitalization(OR=3.882,95% CI=1.340-11.252,p=0.012).A positive statistically significant correlation was found between the patients' hospitalization periods and SARC-F scores(Spearman's rho=0.329,p=0.007),and a negative statistically significant correlation was found between the patients' hospitalization periods and HGS scores.The duration of hospitalization was found to be significantly longer in the patients who had low HGS(19.38±22.25).

Conclusion: SARC-F appears to be a weaker parameter than HGS and a stronger parameter than SMM (BMI) on hospitalization and mortality.

Cite this article as: Coşkun Yavuz Y, Bıyık Z, Korez MK, et al. SARC-F is a weaker predictor compared to muscle strength and a stronger predictor compared to muscle mass for mortality and hospitalization in hemodialysis patients. Turk J Nephrol. 2022;31(4):314-320.

Files
Full Text PDF
EISSN 2667-4440